Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer
about
Beyond CA125: the coming of age of ovarian cancer biomarkersCirculating tumor cells in germ cell tumors: are those biomarkers of real prognostic value? A reviewCharacterization of DNA Methylation in Circulating Tumor CellsCurrent Status of CTCs as Liquid Biopsy in Lung Cancer and Future DirectionsCirculating tumor cells in the diagnosis and management of pancreatic cancerGlucose is a key driver for GLUT1-mediated nanoparticles internalization in breast cancer cellsLeukocyte-adjusted epigenome-wide association studies of blood from solid tumor patientsPilot study: alteration of deleted in liver cancer1 and phosphorylated focal adhesion kinase Y397 cytoplasmic expression and the prognostic value in advanced epithelial ovarian carcinomaCirculating Tumor Cell Isolation and Analysis.Contrast-enhanced ultrasonography in differential diagnosis of benign and malignant ovarian tumors.IgE-based immunotherapy of cancer: challenges and chances.Highly-sensitive capture of circulating tumor cells using micro-ellipse filtersDiagnostic accuracy of DWI in patients with ovarian cancer: A meta-analysis.Prognostic analysis of invasive circulating tumor cells (iCTCs) in epithelial ovarian cancerPharmacogenomic modeling of circulating tumor and invasive cells for prediction of chemotherapy response and resistance in pancreatic cancerA phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer.Prognostic Value of Circulating Tumor Cells in Ovarian Cancer: A Meta-Analysis.A radial flow microfluidic device for ultra-high-throughput affinity-based isolation of circulating tumor cells.Prognostic value of circulating tumor cells and disseminated tumor cells in patients with ovarian cancer: a systematic review and meta-analysisPersonalized Treatment Through Detection and Monitoring of Genetic Aberrations in Single Circulating Tumor Cells.The added value of circulating tumor cells examination in ovarian cancer staging.A universal tumor cell isolation method enabled by fibrin-coated microchannels.High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers.One-step detection of circulating tumor cells in ovarian cancer using enhanced fluorescent silica nanoparticlesIsolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients.Circulating tumor cells as therapy-related biomarkers in cancer patients.Circulating tumor cells as trigger to hematogenous spreads and potential biomarkers to predict the prognosis in ovarian cancer.Detection and enumeration of circulating tumor cells based on their invasive property.Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration-resistant prostate cancer.An integrated microfluidic platform for rapid tumor cell isolation, counting and molecular diagnosis.Materials and microfluidics: enabling the efficient isolation and analysis of circulating tumour cells.Usefulness of transcription-reverse transcription concerted reaction method for detecting circulating tumor cells in patients with colorectal cancer.Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of FcɛRI-mediated basophil activation by a tumour-specific IgE antibody to evaluate the risk of type I hypersensitivity.Circulating tumor cells: silent predictors of metastasis.EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapy.Treatment monitoring of patients with epithelial ovarian cancer using invasive circulating tumor cells (iCTCs).Molecular mechanisms of metastasis.Circulating cell-free DNA and circulating tumor cells, the "liquid biopsies" in ovarian cancer.Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium.Diagnostic value of HE4+ circulating tumor cells in patients with suspicious ovarian cancer.
P2860
Q24651567-56386CC8-02C6-4768-B153-695E5A6DB6F0Q26752116-AB09875D-75DC-4B83-BADE-0DBCD1BE7653Q26778427-834F923F-0639-4986-B39C-CB21071369EEQ26781333-5A82D3EB-6069-45DD-AD86-AF0CE181C7BCQ27027711-248BD84E-96C0-474E-AF9A-787E98529373Q27345982-352F7A10-3A22-48ED-8866-2E8663247683Q28388342-23173367-B41A-4027-B5A1-EBC70FABC706Q28395522-81D32FE9-DBBB-49DA-B598-11312AD0DD1AQ30358229-889C682E-D162-4D4D-9D58-C10C46515E99Q30416321-9DD54A10-74AB-462C-B0EC-232F340F0DF5Q33619979-D9BEEA79-BAEB-4A9F-ACB8-BCE469F240DBQ33670178-2EAE09DE-6F24-494C-A66A-9055AB98296DQ33672451-65434DD1-A3D8-44ED-9C4E-983B6D10F7C5Q34161251-C570B2C7-B28D-452B-A7CA-D9D736C18A3FQ35137142-187FD9EF-8641-4655-9B21-9207FBF2EBB9Q35591666-2E34BD7A-D175-4CEC-8E98-2F7441E01183Q35670613-06DC3ED3-4007-4B28-94A0-0D3A6159C76DQ35681674-2EF8C34F-9600-4BF6-B63E-B1279F692F56Q35775519-08E1E399-D649-4E00-89D6-A6535B8D0429Q36385825-388E3EBE-C42D-4DD0-AA75-7A80598BCCFBQ36420164-EDA5384C-BBFE-497F-B3A3-4096FD3DE051Q36430875-D7EF1430-79EF-4107-AA1B-66D19AD1D3F1Q36532522-6BAEF09F-B0DB-4526-8986-CBC7742AE22FQ36957933-FBA42C9A-24DE-4672-9E4C-99B1A0D07BDBQ37480512-2EB0CDF1-4C15-4CEA-9896-11085A23BF6EQ38073601-D7F2D262-7588-4E9E-9489-9D9810C41224Q38616195-7F1BE8E7-16B8-477C-8C54-4CCB177AAE23Q38845927-8844911B-D908-4FA4-8679-CCE7BC2A07E8Q39069427-E240923C-2A3B-4115-AC0A-34D70BCC7846Q39211338-55E9CB31-83E6-47D0-8DF0-1A05EB89458CQ39385781-DA0C3A51-2E8D-4DEE-9732-22620A3B5247Q39512212-4C16D410-07E9-45CF-BAA3-8AFCC6386311Q39543380-A5495145-6164-4077-962D-6FD605A12C89Q41425998-4CE5E072-3ED2-4B0E-BE4E-C04AE5D3A700Q41472132-1F39BFDB-DD1D-47DF-B13D-1CEEC655CCC7Q41500610-45D13EE0-3E14-492C-ABDD-E72AA4888505Q46055814-C7D55800-3F0D-480B-A6B0-6FB50C142DD3Q47094357-CA8849EC-088A-437E-BE2B-506956D6939CQ47134733-2A48343C-C3A3-4A95-B908-AEA4068481CCQ50328403-B6702E37-4764-450F-8E67-8A6DFE2050C8
P2860
Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical significance of circu ...... f patients with ovarian cancer
@en
Clinical significance of circu ...... patients with ovarian cancer.
@nl
type
label
Clinical significance of circu ...... f patients with ovarian cancer
@en
Clinical significance of circu ...... patients with ovarian cancer.
@nl
prefLabel
Clinical significance of circu ...... f patients with ovarian cancer
@en
Clinical significance of circu ...... patients with ovarian cancer.
@nl
P2093
P2860
P1433
P1476
Clinical significance of circu ...... f patients with ovarian cancer
@en
P2093
John J Chen
Michael L Pearl
Qiang Zhao
Wen-Tien Chen
P2860
P304
P356
10.1016/J.YGYNO.2008.09.021
P407
P577
2008-10-26T00:00:00Z